Acyclovir Tablet Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 200 mg, 400 mg, 800 mg
Reference Brands: Zovirax(US & EU)
Category:
Transplant
Acyclovir is an antiviral that inhibits viral DNA synthesis by targeting thymidine kinase, preventing herpes virus replication. It effectively treats herpes simplex, shingles, and varicella. Benefits include viral suppression, symptom relief, reduced duration of outbreaks, decreased transmission risk, and prevention of complications, supporting long-term herpes management.
Acyclovir tablet is available in Tablets
and strengths such as 200 mg, 400 mg, 800 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Acyclovir tablet is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Acyclovir tablet can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Acyclovir tablets, marketed as Zovirax, are approved in the US by the FDA and in the EU via EMA for treating herpes simplex, varicella-zoster, and herpes zoster infections. Regulatory approval requires comprehensive dossiers including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews detailed clinical trial and quality data for timely approval, while the EMA ensures regional compliance with safety and manufacturing standards. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence to regional regulations supports timely approval, safe use, and worldwide availability, enabling effective antiviral management for herpes and related infections.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing